Citadel Advisors’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.3K Buy
+10,300
New +$71.1K ﹤0.01% 12505
2024
Q3
Sell
-3,600
Closed -$18.5K 14884
2024
Q2
$18.5K Sell
3,600
-12,400
-78% -$73.4K ﹤0.01% 12713
2024
Q1
$85K Buy
+16,000
New +$114K ﹤0.01% 11578
2023
Q4
Sell
-44,400
Closed -$335K 14881
2023
Q3
$335K Sell
44,400
-6,300
-12% -$57.6K ﹤0.01% 8940
2023
Q2
$490K Buy
50,700
+46,100
+1,002% +$282K ﹤0.01% 7985
2023
Q1
$17.4K Sell
4,600
-2,100
-31% -$11.7K ﹤0.01% 13159
2022
Q4
$43.4K Buy
+6,700
New +$55.2K ﹤0.01% 12300
2022
Q1
Sell
-10,400
Closed -$115K 14243
2021
Q4
$115K Sell
10,400
-200
-2% -$1.94K ﹤0.01% 12575
2021
Q3
$98K Sell
10,600
-12,300
-54% -$134K ﹤0.01% 12900
2021
Q2
$258K Buy
22,900
+10,300
+82% +$119K ﹤0.01% 11629
2021
Q1
$134K Buy
+12,600
New +$142K ﹤0.01% 12176

Other funds holding LFCR